Interobserver variability of tumor proliferation index and the importance of semiautomated method for counting Ki-67 in lung carcinoma

Cristian Suciu (Timisoara, Romania), Cristian Suciu, Cristian Oancea, Ovidiu Burlacu, Remus Cornea, Oana Suciu, Marius Raica

Source: International Congress 2016 – Prognostic variables in lung cancer II
Session: Prognostic variables in lung cancer II
Session type: Thematic Poster
Number: 2876
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Cristian Suciu (Timisoara, Romania), Cristian Suciu, Cristian Oancea, Ovidiu Burlacu, Remus Cornea, Oana Suciu, Marius Raica. Interobserver variability of tumor proliferation index and the importance of semiautomated method for counting Ki-67 in lung carcinoma. Eur Respir J 2016; 48: Suppl. 60, 2876

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas
Source: Eur Respir J 2012; 40: 1221-1227
Year: 2012



The importance of Ki-67 proliferation index in small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


Use of a semi-automatic human-supervised procedure for quantitative histology: Modulation of tumour cell dissemination in lung parenchyma
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016

Correlation of diffusion MRI with the Ki-67 index in non-small cell lung cancer
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016

Accuracy of PD-L1 tumour staining of cytological and histological samples of lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018




Inter-reader variation in lung segmentation of functional lung MRI quantification.
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019

Composite anatomical–clinical–molecular prognostic model in nonsmall cell lung cancer
Source: Eur Respir J 2011; 37: 136-142
Year: 2011



Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma
Source: Eur Respir J 2013; 41: 943-951
Year: 2013



Quantitative prognostic markers for NSCLC: the state-of-the-art and methodology
Source: International Congress 2014 – From bench to bedside: biomarkers and biobanking for lung cancer in 2014
Year: 2014

Visual emphysema evaluation on CT: Interobserver agreement and concordance with lung density and lung function
Source: International Congress 2014 – From lung imaging research to clinical use
Year: 2014

RT-PCR and IHC as the alternative methods for detection of ALK aberrations in NSCLC samples - The feasibility study
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015

Validation and comparison of several published prognostic systems for patients with small cell lung cancer
Source: Eur Respir J 2011; 38: 657-663
Year: 2011



Attenuation change of lung nodules according to variation of examination techniques in low dose CT using iterative reconstruction: A phantom study
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016

Interobserver agreement in determining non-small cell lung cancer subtype in specimens acquired by EBUS-TBNA},
Source: Eur Respir J 2012; 40: 699-705
Year: 2012



The evaluation of bromodeoxyuridine labelling index in lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 86s
Year: 2006

Validation of CALIPER (Computer-aided lung informatics for pathology evaluation and rating) for the non-invasive assessment of pulmonary nodules of the adenocarcinoma spectrum
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


Analysis of surgical stage lung cancer and tumour markers prognostic value
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006

Relative contribution of cytological specimen type in the determination of lung cancer histologic identity – Analysis of one year‘s comparative data
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011